• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉郁滞而非输注去氨加压素会引起血浆纤连蛋白增加。

Venostasis but not DDAVP infusion provokes the plasma fibronectin increase.

作者信息

Letowska M, Bykowska K, Sablinski J, Lopaciuk S, Kopeć M

机构信息

Department of Blood Storage and Preparation, Institute of Hematology, Warsaw, Poland.

出版信息

Thromb Haemost. 1990 Oct 22;64(2):294-6.

PMID:2270537
Abstract

Plasma fibronectin (pFN), von Willebrand factor antigen (vWf:Ag), factor VIII procoagulant activity, fibrinogen, euglobulin lysis time (ELT) and hematocrit were determined in healthy blood donors before and after venostasis as well as after intravenous infusion of 1-deamino-8-D-arginine vasopressin (DDAVP). Both venostasis and DDAVP provoked an increase in vWf:Ag and shortening in the ELT. In contrast, venostasis only but not DDAVP induced an increase in pFN levels which was statistically significant with and without correction for a concomitant hematocrit increment. The results indicate that there is a distinct difference in the patterns of venostasis and DDAVP mediated release of proteins from the vessel wall.

摘要

在健康献血者静息前后以及静脉注射1-去氨基-8-D-精氨酸加压素(DDAVP)后,测定血浆纤连蛋白(pFN)、血管性血友病因子抗原(vWf:Ag)、凝血因子VIII促凝活性、纤维蛋白原、优球蛋白溶解时间(ELT)和血细胞比容。静息和DDAVP均引起vWf:Ag增加和ELT缩短。相比之下,仅静息而非DDAVP可诱导pFN水平升高,无论是否校正伴随的血细胞比容增加,该升高均具有统计学意义。结果表明,静息和DDAVP介导的血管壁蛋白释放模式存在明显差异。

相似文献

1
Venostasis but not DDAVP infusion provokes the plasma fibronectin increase.静脉郁滞而非输注去氨加压素会引起血浆纤连蛋白增加。
Thromb Haemost. 1990 Oct 22;64(2):294-6.
2
Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.输注去氨加压素(DDAVP)后的尿毒症血浆可改善正常血小板与血管内皮下层的相互作用。
J Lab Clin Med. 1989 Jul;114(1):36-42.
3
Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.血管性血友病中血管壁对去氨加压素和静脉阻塞的分泌反应。
Acta Haematol Pol. 1994;25(3):261-8.
4
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.1型和2型先天性血管性血友病患者血管性血友病因子参数对去氨加压素的反应:诊断和治疗意义
Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814.
5
DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor.去氨加压素对甲型血友病携带者的输注:血浆凝血因子 VIII 和血管性血友病因子的不同表现
Blood Coagul Fibrinolysis. 1996 Jul;7(5):549-53.
6
Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.去氨加压素对先天性出血性疾病患儿止血作用的评估。
Haemophilia. 2008 May;14(3):524-30. doi: 10.1111/j.1365-2516.2008.01672.x. Epub 2008 Feb 18.
7
Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects.健康受试者经静脉和皮下途径给予去氨基-D-精氨酸加压素(DDAVP)后的纤溶和止血反应。
Thromb Haemost. 1988 Feb 25;59(1):34-9.
8
1-Desamino-8-D-arginine vasopressin (DDAVP) in patients with congenital nephrogenic diabetes insipidus.1-去氨基-8-D-精氨酸加压素(DDAVP)用于先天性肾性尿崩症患者。
Neth J Med. 1993 Aug;43(1-2):5-12.
9
Multimeric analysis of von Willebrand factor before and after desmopressin acetate (DDAVP) administration intravenously and subcutaneously in male beagle dogs.在雄性比格犬中静脉内和皮下给予醋酸去氨加压素(DDAVP)前后对血管性血友病因子进行多聚体分析。
Am J Vet Res. 1987 Sep;48(9):1376-9.
10
Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.甲型血友病合并Ⅰ型血管性血友病:一项家族研究,包括对去氨加压素输注效果的评估。
Haematologia (Budap). 1993;25(1):57-67.